铂-话题@MedSci

#铂#

382篇内容 | 7526人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1737558, encodeId=2b121e375582d, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=顺铂脂质体治疗乳腺癌获积极临床结果, objectType=article, longId=128622, objectId=6ea6128622a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ea6128622a4, replyNumber=0, likeNumber=66, createdTime=2018-02-11, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ea6128622a4, moduleTitle=顺铂脂质体治疗乳腺癌获积极临床结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ea6128622a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737577, encodeId=39451e3757735, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=NEJM：硫代硫酸钠可降低顺铂治疗导致的听力损伤风险, objectType=article, longId=141259, objectId=2fd91412599f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fd91412599f, replyNumber=0, likeNumber=97, createdTime=2018-06-26, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fd91412599f, moduleTitle=NEJM：硫代硫酸钠可降低顺铂治疗导致的听力损伤风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fd91412599f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737590, encodeId=c2301e375908c, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=2018年AAO-HNSF：N-乙酰半胱氨酸对顺铂诱导的耳毒性的保护作用, objectType=article, longId=150998, objectId=450c150998b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=450c150998b6, replyNumber=0, likeNumber=82, createdTime=2018-12-03, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=450c150998b6, moduleTitle=2018年AAO-HNSF：N-乙酰半胱氨酸对顺铂诱导的耳毒性的保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=450c150998b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737552, encodeId=ecf61e3755256, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=依维莫司维持治疗原发性铂类耐药卵巢透明细胞癌一例, objectType=article, longId=124873, objectId=cba21248e361, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cba21248e361, replyNumber=0, likeNumber=86, createdTime=2018-07-02, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cba21248e361, moduleTitle=依维莫司维持治疗原发性铂类耐药卵巢透明细胞癌一例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cba21248e361)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737561, encodeId=84f01e375613a, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=J Clin Periodontol：顺铂化疗对钛种植体周围骨修复的影响, objectType=article, longId=130292, objectId=2a04130292b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a04130292b0, replyNumber=0, likeNumber=74, createdTime=2018-12-27, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a04130292b0, moduleTitle=J Clin Periodontol：顺铂化疗对钛种植体周围骨修复的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a04130292b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737556, encodeId=3b6f1e37556a5, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Ann Oncol：顺铂+西妥昔单抗+再放疗对于复发性或第二原发性头颈部鳞状细胞癌患者可行, objectType=article, longId=127049, objectId=a3f612e04938, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3f612e04938, replyNumber=0, likeNumber=89, createdTime=2018-04-26, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3f612e04938, moduleTitle=Ann Oncol：顺铂+西妥昔单抗+再放疗对于复发性或第二原发性头颈部鳞状细胞癌患者可行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3f612e04938)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737572, encodeId=b9fc1e37572a4, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=JCO：紫杉醇+S-1与顺铂+S-1比较治疗胃癌腹膜转移患者, objectType=article, longId=138011, objectId=e39d13801165, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e39d13801165, replyNumber=0, likeNumber=63, createdTime=2019-03-27, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e39d13801165, moduleTitle=JCO：紫杉醇+S-1与顺铂+S-1比较治疗胃癌腹膜转移患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e39d13801165)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737574, encodeId=8e221e37574e2, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=铂类药物临床应用与不良反应管理专家共识, objectType=article, longId=139242, objectId=935013924208, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=935013924208, replyNumber=0, likeNumber=19, createdTime=2019-03-24, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=935013924208, moduleTitle=铂类药物临床应用与不良反应管理专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=935013924208)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737537, encodeId=ed761e3753768, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet oncol：派姆单抗用于不能用顺铂化疗的晚期尿路上皮肿瘤患者的疗效和安全性。, objectType=article, longId=114396, objectId=95c311439626, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95c311439626, replyNumber=0, likeNumber=58, createdTime=2017-10-17, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95c311439626, moduleTitle=Lancet oncol：派姆单抗用于不能用顺铂化疗的晚期尿路上皮肿瘤患者的疗效和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95c311439626)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737576, encodeId=1b171e37576e9, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Brit J Cancer：Apatorsen与多烯紫杉醇结合治疗与多烯紫杉醇单独治疗铂抵抗性转移尿路上皮癌的比较研究, objectType=article, longId=140374, objectId=91e81403e4fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91e81403e4fd, replyNumber=0, likeNumber=63, createdTime=2019-02-18, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91e81403e4fd, moduleTitle=Brit J Cancer：Apatorsen与多烯紫杉醇结合治疗与多烯紫杉醇单独治疗铂抵抗性转移尿路上皮癌的比较研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91e81403e4fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737543, encodeId=cea41e3754302, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet oncol：多西他赛、卡铂化疗，联合曲妥珠单抗和帕托珠单抗治疗HER2阳性乳腺癌患者的疗效与副反应。, objectType=article, longId=121373, objectId=6a6c1213e360, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a6c1213e360, replyNumber=0, likeNumber=76, createdTime=2018-01-19, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a6c1213e360, moduleTitle=Lancet oncol：多西他赛、卡铂化疗，联合曲妥珠单抗和帕托珠单抗治疗HER2阳性乳腺癌患者的疗效与副反应。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a6c1213e360)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737555, encodeId=0f4f1e37555a5, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Ann Oncol：顺铂+西妥昔单抗+再放疗对于复发性或第二原发性头颈部鳞状细胞癌患者可行, objectType=article, longId=127050, objectId=34ed12e050b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34ed12e050b3, replyNumber=0, likeNumber=86, createdTime=2018-03-13, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34ed12e050b3, moduleTitle=Ann Oncol：顺铂+西妥昔单抗+再放疗对于复发性或第二原发性头颈部鳞状细胞癌患者可行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34ed12e050b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737551, encodeId=9e6a1e3755176, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=J Clin Oncol：顺铂放化疗治疗局部晚期头颈癌：每周一次好还是每周三次好？, objectType=article, longId=124124, objectId=0703124124e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0703124124e3, replyNumber=0, likeNumber=70, createdTime=2018-10-14, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0703124124e3, moduleTitle=J Clin Oncol：顺铂放化疗治疗局部晚期头颈癌：每周一次好还是每周三次好？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0703124124e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737545, encodeId=8cc71e3754556, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet oncol：Avelumab，抗PD-L1单克隆抗体，为对铂类不敏感的转移性尿路上皮癌患者带来新的希望。, objectType=article, longId=122363, objectId=cb2d122363b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb2d122363b2, replyNumber=0, likeNumber=74, createdTime=2018-07-10, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb2d122363b2, moduleTitle=Lancet oncol：Avelumab，抗PD-L1单克隆抗体，为对铂类不敏感的转移性尿路上皮癌患者带来新的希望。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb2d122363b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737540, encodeId=f3b11e3754049, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=ANN ONCOL：S-1与多西他赛治疗铂基化疗后非小细胞肺癌患者的疗效对比, objectType=article, longId=119384, objectId=6bb111938437, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bb111938437, replyNumber=0, likeNumber=95, createdTime=2018-06-04, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bb111938437, moduleTitle=ANN ONCOL：S-1与多西他赛治疗铂基化疗后非小细胞肺癌患者的疗效对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bb111938437)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737550, encodeId=5ddb1e3755071, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=EUR J CANCER：多西紫杉醇 vs多西紫杉醇联合卡铂治疗去势难治性前列腺癌的随机II期临床试验：RECARDO试验, objectType=article, longId=124106, objectId=bed9124106d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bed9124106d6, replyNumber=0, likeNumber=66, createdTime=2018-03-31, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bed9124106d6, moduleTitle=EUR J CANCER：多西紫杉醇 vs多西紫杉醇联合卡铂治疗去势难治性前列腺癌的随机II期临床试验：RECARDO试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bed9124106d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737527, encodeId=4d1f1e3752721, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Invest New Drugs.：贝伐单抗联合吉西他滨+奥沙利铂能够改善晚期胆道癌的生存率。, objectType=article, longId=107623, objectId=b4b610e62312, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4b610e62312, replyNumber=0, likeNumber=102, createdTime=2018-04-07, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4b610e62312, moduleTitle=Invest New Drugs.：贝伐单抗联合吉西他滨+奥沙利铂能够改善晚期胆道癌的生存率。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4b610e62312)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737564, encodeId=d7831e375640c, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet Oncol：奈达铂治疗晚期鼻咽癌效果非劣于顺铂, objectType=article, longId=131096, objectId=844413109669, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=844413109669, replyNumber=0, likeNumber=59, createdTime=2018-07-04, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=844413109669, moduleTitle=Lancet Oncol：奈达铂治疗晚期鼻咽癌效果非劣于顺铂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=844413109669)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737529, encodeId=accd1e375298e, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Int J Otolaryngol：线粒体DNA单倍群和顺铂诱导听力损失关系的缺乏, objectType=article, longId=108145, objectId=31451081456d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31451081456d, replyNumber=0, likeNumber=91, createdTime=2017-10-22, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31451081456d, moduleTitle=Int J Otolaryngol：线粒体DNA单倍群和顺铂诱导听力损失关系的缺乏, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31451081456d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737546, encodeId=a8ae1e3754605, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=JACC：铂铬合金依维莫司洗脱支架用于冠脉疾病的长期安全性和疗效, objectType=article, longId=123059, objectId=9eb6123059d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9eb6123059d4, replyNumber=0, likeNumber=103, createdTime=2018-03-16, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9eb6123059d4, moduleTitle=JACC：铂铬合金依维莫司洗脱支架用于冠脉疾病的长期安全性和疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9eb6123059d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

铂

2020-05-29

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

顺铂脂质体治疗乳腺癌获积极临床结果

2018-02-11

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

NEJM：硫代硫酸钠可降低顺铂治疗导致的听力损伤风险

2018-06-26

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

2018年AAO-HNSF：N-乙酰半胱氨酸对顺铂诱导的耳毒性的保护作用

2018-12-03

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

依维莫司维持治疗原发性铂类耐药卵巢透明细胞癌一例

2018-07-02

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

J Clin Periodontol：顺铂化疗对钛种植体周围骨修复的影响

2018-12-27

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Ann Oncol：顺铂+西妥昔单抗+再放疗对于复发性或第二原发性头颈部鳞状细胞癌患者可行

2018-04-26

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

JCO：紫杉醇+S-1与顺铂+S-1比较治疗胃癌腹膜转移患者

2019-03-27

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

铂类药物临床应用与不良反应管理专家共识

2019-03-24

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Lancet oncol：派姆单抗用于不能用顺铂化疗的晚期尿路上皮肿瘤患者的疗效和安全性。

2017-10-17

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Brit J Cancer：Apatorsen与多烯紫杉醇结合治疗与多烯紫杉醇单独治疗铂抵抗性转移尿路上皮癌的比较研究

2019-02-18

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Lancet oncol：多西他赛、卡铂化疗，联合曲妥珠单抗和帕托珠单抗治疗HER2阳性乳腺癌患者的疗效与副反应。

2018-01-19

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Ann Oncol：顺铂+西妥昔单抗+再放疗对于复发性或第二原发性头颈部鳞状细胞癌患者可行

2018-03-13

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

J Clin Oncol：顺铂放化疗治疗局部晚期头颈癌：每周一次好还是每周三次好？

2018-10-14

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Lancet oncol：Avelumab，抗PD-L1单克隆抗体，为对铂类不敏感的转移性尿路上皮癌患者带来新的希望。

2018-07-10

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

ANN ONCOL：S-1与多西他赛治疗铂基化疗后非小细胞肺癌患者的疗效对比

2018-06-04

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

EUR J CANCER：多西紫杉醇 vs多西紫杉醇联合卡铂治疗去势难治性前列腺癌的随机II期临床试验：RECARDO试验

2018-03-31

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Invest New Drugs.：贝伐单抗联合吉西他滨+奥沙利铂能够改善晚期胆道癌的生存率。

2018-04-07

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Lancet Oncol：奈达铂治疗晚期鼻咽癌效果非劣于顺铂

2018-07-04

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Int J Otolaryngol：线粒体DNA单倍群和顺铂诱导听力损失关系的缺乏

2017-10-22

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

JACC：铂铬合金依维莫司洗脱支架用于冠脉疾病的长期安全性和疗效

2018-03-16

科室
- - 订阅+
  - 更多科室
工具
服务